Hepatocellular carcinoma: diagnostics and screening (Q37813192)

23 August 2017

1 reference

title

Hepatocellular carcinoma: diagnostics and screening (English)

1 reference

23 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

Simon D Taylor-Robinson

7

object named as

Simon D Taylor-Robinson

1 reference

23 August 2017

Madhvi Patel

1

1 reference

23 August 2017

Mohamed I F Shariff

2

1 reference

23 August 2017

Nimzing G Ladep

3

1 reference

23 August 2017

Andrew V Thillainayagam

4

1 reference

23 August 2017

Howard C Thomas

5

1 reference

23 August 2017

Shahid A Khan

6

1 reference

23 August 2017

30 November 2010

1 reference

Journal of Evaluation in Clinical Practice

23 August 2017

1 reference

23 August 2017

18

1 reference

23 August 2017

2

1 reference

23 August 2017

335-342

1 reference

Management of hepatocellular carcinoma

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Radiological diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Present and future possibilities for early diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Moderate alcohol intake and cancer incidence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Randomized controlled trial of screening for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

21 January 2018

Imaging of liver cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Hepatocellular carcinoma: multidetector row helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Diagnosis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Systems biology: Metabonomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Proteomics for hepatocellular carcinoma marker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

Ultrasound of focal liver lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2010.01599.X

10.1111/J.1365-2753.2010.01599.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference